000 01902 a2200469 4500
005 20250515050116.0
264 0 _c20080815
008 200808s 0 0 eng d
022 _a1198-743X
024 7 _a10.1111/j.1469-0691.2006.01552.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTimen, A
245 0 0 _aPublic health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.
_h[electronic resource]
260 _bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_cDec 2006
300 _a1214-20 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Viral
_xblood
650 0 4 _aCommunicable Disease Control
_xmethods
650 0 4 _aDisease Outbreaks
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfection Control
_xmethods
650 0 4 _aMale
650 0 4 _aNetherlands
_xepidemiology
650 0 4 _aPopulation Surveillance
650 0 4 _aPublic Health
_xstandards
650 0 4 _aReference Standards
650 0 4 _aResource Allocation
650 0 4 _aRetrospective Studies
650 0 4 _aSevere acute respiratory syndrome-related coronavirus
_xgenetics
650 0 4 _aSensitivity and Specificity
650 0 4 _aSevere Acute Respiratory Syndrome
_xdiagnosis
650 0 4 _aWorld Health Organization
700 1 _avan Doornum, G J J
700 1 _aSchutten, M
700 1 _aConyn-van Spaendonck, M A E
700 1 _avan der Meer, J W M
700 1 _aOsterhaus, A D M E
700 1 _avan Steenbergen, J E
773 0 _tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_gvol. 12
_gno. 12
_gp. 1214-20
856 4 0 _uhttps://doi.org/10.1111/j.1469-0691.2006.01552.x
_zAvailable from publisher's website
999 _c16693058
_d16693058